Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Platelet Antagonists in Migraine Prophylaxis A Clinical Trial Using Aspirin and Dipyridamole
Brent E. Masel
, Andrew L. Chesson
, Bruce H. Peters
, Harvey S. Levin
, Jack B. Alperin
Research output
:
Contribution to journal
›
Article
›
peer-review
26
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Platelet Antagonists in Migraine Prophylaxis A Clinical Trial Using Aspirin and Dipyridamole'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Placebo
100%
Clinical Trials
100%
Aspirin
100%
Dipyridamole
100%
Platelet Antagonists
100%
Migraine Prophylaxis
100%
Platelet Hyperaggregability
100%
Headache
66%
Platelet Aggregation
33%
Activity Limitations
33%
Migraine
33%
Pharmacological Effects
33%
Aggregation Studies
33%
Platelet Aggregability
33%
Pretreatment Conditions
33%
Subjective Improvement
33%
Activity Intensity
33%
Headache Frequency
33%
Migraine Patients
33%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Acetylsalicylic Acid
100%
Migraine
100%
Dipyridamole
100%
Placebo
60%
Headache
60%
Side Effect
20%